EX-99.1 2 dex991.htm UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS Unaudited Pro Forma Consolidated Financial Statements

Exhibit 99.1

Marsh & McLennan Companies, Inc.

Note to Unaudited Pro Form Consolidated Financial Statements

Note 1 – Basis of Presentation

The unaudited pro forma financial information reflects the impact of the dispositions of Kroll Inc. and Kroll Laboratory Specialists (“Kroll”) on MMC’s operating results. The unaudited pro forma balance sheet as of March 31, 2010 is based on historical statements of MMC as of March 31, 2010, adjusted to reflect the impact of the disposition of the Kroll operations as if it had occurred on March 31, 2010. The unaudited pro forma statements of operations for the three months ended March 31, 2010 and the fiscal year ended December 31, 2009 are based on the historical financial statements of MMC for such periods after giving effect to the Kroll disposition as if it had occurred on January 1, 2009. The unaudited pro forma financial information should be read in conjunction with MMC’s consolidated financial statements and notes thereto contained in MMC’s 2009 Annual Report of Form 10-K filed on February 26, 2010, and MMC’s Quarterly Report on Form 10-Q for the three months ended March 31, 2010, filed on May 7, 2010.

The preparation of the unaudited pro forma consolidated financial information is based on financial statements prepared in accordance with accounting principles generally accepted in the United States of America. These principles require the use of estimates that affect the reported amounts of revenues and expenses. Actual results could differ from those estimates.

The unaudited pro forma consolidated financial information is provided for illustrative purposes only and does not purport to represent what the actual results of operations would have been had the transactions occurred on the respective date assumed, nor is it necessarily indicative of the Company’s future operating results. However, the pro forma adjustments reflected in the accompanying unaudited pro forma consolidated financial information reflect estimates and assumptions that the Company’s management believes to be reasonable.


Marsh & McLennan Companies, Inc.

Pro Forma Consolidated Statements of Income

Three-Months Ended March 31, 2010

(In millions, except per share figures)

(Unaudited)

 

     MMC
As Reported
    Kroll
Disposition (1)
    MMC
Pro Forma
 

Revenue

   $ 2,795      $ (160   $ 2,635   
        

Expense:

      

Compensation and Benefits

     1,650        (75     1,575   

Other Operating Expenses

     706        (71     635   

Goodwill Impairment Charge

     —            —     
        

Total Expense

     2,356        (146     2,210   
        

Operating Income

     439        (14     425   

Interest Income

     4          4   

Interest Expense

     (60       (60

Investment Income (Loss)

     8          8   
        

Income Before Income Taxes

     391        (14     377   

Income Tax Expense

     117        (14     103   
        

Income From Continuing Operations

     274        —          274   

Less: Income Attributable to Non Controlling Interest

     4        —          4   
        

Income From Continuing Operations Attributable to MMC

   $ 270      $      $ 270   
        

Income From Continuing Operations Per Share

      

Basic

   $ 0.50        $ 0.50   
        

Fully Diluted

   $ 0.49        $ 0.49   
        

Average Number of Shares Outstanding

      

Basic

     533          533   
                  

Fully Diluted

     536          536   
                  

Shares Outstanding at 12/31

     541          541   
                  

 

(1) Adjustment to eliminate operating results of Kroll and Kroll Laboratory Specialists.


Marsh & McLennan Companies, Inc.

Pro Forma Consolidated Statements of Income

Year Ended December 31, 2009

(In millions, except per share figures)

(Unaudited)

 

     MMC
As Reported
    Kroll
Disposition (1)
    MMC
Pro Forma
 

Revenue

   $ 10,493      $ (662   $ 9,831   
        

Expense:

      

Compensation and Benefits

     6,484        (302     6,182   

Other Operating Expenses

     3,185        (314     2,871   

Goodwill Impairment Charge

     315        (315     —     
        

Total Expense

     9,984        (931     9,053   
        

Operating Income

     509        269        778   

Interest Income

     17          17   

Interest Expense

     (241       (241

Investment Income (Loss)

     (2       (2
        

Income Before Income Taxes

     283        269        552   

Income Tax Expense

     41        (20     21   
        

Income From Continuing Operations

     242        289        531   

Less: Income Attributable to Non Controlling Interest

     15        (1     14   
        

Income From Continuing Operations Attributable to MMC

   $ 227      $ 290      $ 517   
        

Income From Continuing Operations Per Share

      

Basic

   $ 0.43        $ 0.97   
        

Fully Diluted

   $ 0.43        $ 0.96   
        

Average Number of Shares Outstanding

      

Basic

     522          522   
                  

Fully Diluted

     524          524   
                  

Shares Outstanding at 12/31

     530          530   
                  

 

(1) Adjustment to eliminate operating results of Kroll and Kroll Laboratory Specialists.


Marsh & McLennan Companies, Inc.

Pro Forma Consolidated Statements of Income

Year Ended December 31, 2008

(In millions, except per share figures)

(Unaudited)

 

     MMC
As Reported
    Kroll
Disposition (1)
    MMC
Pro Forma
 

Revenue

   $ 11,518      $ (788   $ 10,730   
        

Expense:

      

Compensation and Benefits

     7,181        (351     6,830   

Other Operating Expenses

     3,549        (328     3,212   

Goodwill Impairment Charge

     540        (540     —     
        

Total Expense

     11,270        (1,219     10,051   
        

Operating Income

     248        431        679   

Interest Income

     48        -1        47   

Interest Expense

     (220       (220

Investment Income (Loss)

     (12       (12
        

Income Before Income Taxes

     64        430        494   

Income Tax Expense

     133        (20     113   
        

Income (Loss) From Continuing Operations

     (69     450        381   

Less: Income Attributable to Non Controlling Interest

     11          11   
        

Income (Loss) From Continuing Operations Attributable to MMC

   $ (80   $ 450      $ 370   
        

Income (Loss) From Continuing Operations Per Share

      

Basic

   $ (0.14     $ 0.70   
        

Fully Diluted

   $ (0.15     $ 0.70   
        

Average Number of Shares Outstanding

      

Basic

     514          514   
                  

Fully Diluted

     514          515   
                  

Shares Outstanding at 12/31

     514          514   
                  

 

(1) Adjustment to eliminate operating results of Kroll and Kroll Laboratory Specialists.


Marsh & McLennan Companies, Inc.

Pro Forma Consolidated Statements of Income

Year Ended December 31, 2007

(In millions, except per share figures)

(Unaudited)

 

     MMC
As Reported
    Kroll
Disposition (1)
    MMC
Pro Forma
 

Revenue

   $ 11,135      $ (758   $ 10,377   
        

Expense:

      

Compensation and Benefits

     6,937        (367     6,570   

Other Operating Expenses

     3,344        (301     3,043   

Goodwill Impairment Charge

     —          —          —     
        

Total Expense

     10,281        (668     9,613   
        

Operating Income

     854        (90     764   

Interest Income

     95        0        95   

Interest Expense

     (267     1        (266

Investment Income (Loss)

     173          173   
        

Income Before Income Taxes

     855        (89     766   

Income Tax Expense

     298        (20     278   
        

Income From Continuing Operations

     557        (69     488   

Less: Income Attributable to Non Controlling Interest

     14        —          14   
        

Income From Continuing Operations Attributable to MMC

   $ 543      $ (69   $ 474   
        

Income From Continuing Operations Per Share

      

Basic

   $ 0.98        $ 0.86   
        

Fully Diluted

   $ 0.98        $ 0.85   
        

Average Number of Shares Outstanding

      

Basic

     539          539   
                  

Fully Diluted

     542          542   
                  

Shares Outstanding at 12/31

     520          520   
                  

 

(1) Adjustment to eliminate operating results of Kroll and Kroll Laboratory Specialists.


Marsh & McLennan Companies, Inc.

Pro Forma Consolidated Balance Sheet

March 31, 2010

(In millions)

(Unaudited)

     MMC
As Reported
    Kroll
Disposition (1)
    Pro-forma
Adjustments
    MMC
Pro-Forma
 

ASSETS

        

Current assets:

        

Cash and cash equivalents

   $ 1,167      $        $ 1,092 (2)    $ 2,259   

Net receivables

     2,935        (134     265 (3)      3,066   

Other current assets

     490        (12       478   
        

Total current assets

     4,592        (146     1,357        5,803   

Goodwill and intangible assets

     7,250        (861       6,389   

Fixed assets, net

     920        (92       828   

Pension-related Assets

     140            140   

Deferred tax Assets

     1,096        (20       1,076   

Other assets

     964        (14       950   
        

TOTAL ASSETS

   $ 14,962      $ (1,133   $ 1,357      $ 15,186   
        

LIABILITIES AND STOCKHOLDERS’ EQUITY

        

Current liabilities:

        

Short-term debt

   $ 558      $        $        $ 558   

Accounts payable and accrued liabilities

     1,870        (61       1,809   

Accrued compensation and employee benefits

     637        (22       615   

Accrued income taxes

     —          —            —     

Dividends payable

     109            109   
        

Total current liabilities

     3,174        (83       3,091   

Fiduciary liabilities

     3,909            3,909   

Less—cash and investments held in a fiduciary capacity

     (3,909         (3,909
        
     —              —     

Long-term debt

     3,032            3,032   

Pension, postretirement and postemployment benefits

     1,163        (2       1,161   

Liabilities for errors and omissions

     517            517   

Other liabilities

     1,062        (2       1,060   

Common stock

     561            561   

Additional paid-in capital

     1,109            1,109   

Retained earnings

     7,062        (1,056     1,357 (2,3)      7,363   

Accumulated other comprehensive loss

     (2,246     10          (2,236

Non-controlling interest

     37            37   
        
     6,523        (1,046     1,357        6,834   

Less: Treasury shares, at cost

     (509         (509
        

Total stockholders’ equity

     6,014        (1,046     1,357        6,325   
        

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

   $ 14,962      $ (1,133   $ 1,357      $ 15,186   
        

 

(1) Adjustment to eliminate the Kroll balance sheet at March 31, 2010. This excludes approximately $400 million of cash and intercompany balances that were settled with MMC and its subsidiaries and certain investments and other receivables that have been transferred to MMC.
(2) Adjustment to reflect the cash proceeds on the sale of Kroll, including an estimated working capital adjustment, net of transaction expenses of approximately $50 million (i.e., investment banking fees, legal fees, audit fees, etc.).
(3) Adjustment for the estimated tax benefit from the disposal of Kroll.